Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rani Therapeutics Holdings (RANI) Long-Term Debt Issuances (2020 - 2022)

Historic Long-Term Debt Issuances for Rani Therapeutics Holdings (RANI) over the last 3 years, with Q4 2022 value amounting to $14.9 million.

  • Rani Therapeutics Holdings' Long-Term Debt Issuances changed N/A to $14.9 million in Q4 2022 from the same period last year, while for Dec 2023 it was $29.6 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $29.6 million for FY2022, which is 161941.86% up from last year.
  • Per Rani Therapeutics Holdings' latest filing, its Long-Term Debt Issuances stood at $14.9 million for Q4 2022.
  • In the past 5 years, Rani Therapeutics Holdings' Long-Term Debt Issuances registered a high of $14.9 million during Q4 2022, and its lowest value of $1.7 million during Q1 2021.
  • Its 3-year average for Long-Term Debt Issuances is $8.5 million, with a median of $8.7 million in 2020.